PRCT Earnings

PRCT reported its earnings on 2026-02-25, showcasing a revenue of against an estimate of 93.70M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.32 by 0%. The stock experienced a -15.12% price change on the earnings day and a -5.68% change over the next five days, reflecting market reactions to the results.

Following PRCT's earnings announcement on 2026-02-25, the stock price moved by -15.12% on the day of the release. Over the subsequent five days, it saw a -5.68% change. Historically, PRCT's stock price tends to shift by an average of 2.82% in the 10 days leading up to earnings and -0.85% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate PRCT's annual revenue to reach 92.20M, while the EPS is projected at -0.31. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between PRCT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, PRCT's stock price typically moves by 2.82% in the 10 days before its earnings and -0.85% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.31 and revenue of 92.20M.

The earnings call reveals a mixed performance with strong revenue growth and improved gross margins, but significant concerns arise from increased losses, higher operating expenses, and weak Q4 handpiece sales. While guidance for 2026 shows potential, the immediate impact of discontinuing bulk discounts, increased ASP, and the sales force realignment creates uncertainty. The Q&A session highlights management's confidence in future growth but lacks concrete evidence for some claims. Given the market cap and these factors, a negative stock price reaction is expected.